Emergency Preparedness and Response

Counterterrorism and Emerging Threats

Montage of photos representing OCET activities, including scientists conducting research, professional development activities, and law books and gavel representing regulatory functions 

FDA plays a critical role in protecting the United States from chemical, biological, radiological, nuclear, and emerging infectious disease threats. FDA ensures that medical countermeasures (MCMs)—including drugs, vaccines and diagnostic tests—to counter these threats are safe, effective, and secure.

Learn more about the Medical Countermeasures Initiative (MCMi)

Follow Us On Twitter Follow us on Twitter @FDA_MCMi disclaimer icon


Sign up to receive email alerts on emergency preparedness and response topics from FDA, including medical countermeasures and emerging infectious diseases.

Contact FDA

FDA's Office of Counterterrorism and Emerging Threats

Michael Mair, MPH

Acting Assistant Commissioner for Counterterrorism Policy, and Acting Director, Office of Counterterrorism and Emerging Threats

Page Last Updated: 10/23/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English